| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | LABCORP HOLDINGS INC CMN | Jun 30, 2026 | |
| Sell | LABCORP HOLDINGS INC | May 12, 2026 | |
| Buy | Labcorp Holdings Inc. Common | Mar 27, 2026 | |
| Buy | Labcorp Holdings Inc. Common | Feb 11, 2026 | |
| Buy | Labcorp Holdings Inc. Common | Feb 4, 2026 | |
| Buy | Labcorp Holdings Inc. Common | Jan 28, 2026 | |
| Buy | Labcorp Holdings Inc. Common | Nov 17, 2025 | |
| Buy | Labcorp Holdings Inc. Common | Oct 31, 2025 | |
| Buy | Labcorp Holdings Inc. Common | Oct 29, 2025 | |
| Buy | LABCORP HOLDINGS INC CMN | Jun 27, 2025 |
This page tracks congressional stock trading activity in Labcorp Holdings Inc. (LH) in the Healthcare sector. Disclosed Capitol has indexed 104 disclosed congressional trades involving LH. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 104 disclosed congressional trades in Labcorp Holdings Inc. (LH) — 41:37 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 30, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| May 12, 2026 | Michael McCaul | R | Sell | $100,001 - $250,000 |
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Feb 11, 2026 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Feb 4, 2026 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Jan 28, 2026 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Nov 17, 2025 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Oct 31, 2025 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Oct 29, 2025 | April McClain Delaney | D | Buy | $1,001 - $15,000 |
| Jun 27, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
Across the 104 disclosed congressional trades in Labcorp Holdings Inc. (LH), members of Congress have reported 37 buys and 41 sells. The average 30-day alpha vs. the S&P 500 is -0.39%.
For fiscal year 2025, Labcorp Holdings Inc. reported revenue of $13.95B and net income of $876.5M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $7.27B, net income $576.5M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.